Banyan BioInnovations Launches as an Investment Firm to Support Clinical-Stage Drug Assets, Secures More Than $100M in Initial Commitments from Life Science Investors

B Leverages Locust Walk’s global asset sourcing capabilities across the US, Asia, and Europe to co-found NewCos with drug originators Provides comprehensive support to accelerate and de-risk…
posteditor
posteditor
Articles: 21727

Other News